Does Dr. Ey study pancreatic cancer?

Yes, Dr. Ey researches metastatic pancreatic cancer, particularly focusing on personalized treatment strategies using a combination of therapies.

What conditions does Dr. Ey focus on?

Dr. Ey focuses on metastatic pancreatic cancer and sickle cell anemia, aiming to improve treatment outcomes for patients with these challenging diseases.

Is Dr. Ey's work relevant for sickle cell anemia patients?

Yes, his research on the cell membranes of sickle cells could lead to better understanding and treatment options for sickle cell anemia patients.

FREDERICK S. EY, M.D.

BEAVERTON, OR

Research Active

Internal Medicine - Hematology & Oncology NPI registered 21+ years 2 publications 1997 – 2021 NPI: 1326041948

Internal Medicine - Hematology & Oncology

Mutation Erythrocytes Pancreatic Neoplasms Neoplasm Recurrence, Local Adenocarcinoma Germ-Line Mutation Fatty Acids Anemia, Sickle Cell Biology Glycolipids Membrane Lipids Phosphatidic Acids Phospholipids

Practice Location

15700 SW GREYSTONE COURT
BEAVERTON, OR 97006-0000

Phone: (503) 203-1000

What does FREDERICK EY research?

Dr. Ey studies complex diseases, particularly metastatic pancreatic cancer and sickle cell anemia, which both have significant challenges regarding treatment and patient survival. He explores how different treatment combinations and genetic factors can affect patient outcomes, and his work has shown promise for personalized approaches to manage these conditions. In pancreatic cancer, he looks at how tailored therapies, such as combining chemotherapy, targeted therapy, and surgery, can lead to long-term recovery. For sickle cell anemia, he investigates the molecular changes in red blood cells that contribute to the disease's complications, aiming to improve future treatment options.

Key findings

In a study on metastatic pancreatic cancer, a patient with a specific genetic mutation was cancer-free for four years after receiving multimodal treatment, highlighting the potential of tailored therapies.
Research on sickle cell anemia found 12 abnormal types of fatty acids in sickle cells, with some levels being 20-60% higher or lower than in healthy cells, which may contribute to severe complications of the disease.
The findings suggest that understanding and manipulating these molecular changes in sickle cell patients could lead to improved strategies for managing their symptoms.

Frequently asked questions

Does Dr. Ey study pancreatic cancer?: Yes, Dr. Ey researches metastatic pancreatic cancer, particularly focusing on personalized treatment strategies using a combination of therapies.
What conditions does Dr. Ey focus on?: Dr. Ey focuses on metastatic pancreatic cancer and sickle cell anemia, aiming to improve treatment outcomes for patients with these challenging diseases.
Is Dr. Ey's work relevant for sickle cell anemia patients?: Yes, his research on the cell membranes of sickle cells could lead to better understanding and treatment options for sickle cell anemia patients.

Publications in plain English

Multimodality therapy in metastatic pancreas cancer with amutation and durable long-term outcome: biology, intervention, or both?

2021

Cancer biology & therapy

Sutton TL, Grossberg A, Ey F, O'Reilly EM, Sheppard BC

Plain English
This study looked at a patient with metastatic pancreatic cancer who had a specific genetic mutation. The patient received a combination of treatments, including chemotherapy, targeted therapy, and surgery, and has been cancer-free for four years. This case is important because it shows how tailored treatments and a team approach can lead to better outcomes in a disease that typically has a very low survival rate. Who this helps: This benefits patients with metastatic pancreatic cancer and their doctors by providing hope for better treatment strategies.

PubMed

Abnormal phospholipid molecular species of erythrocytes in sickle cell anemia.

1997

Journal of lipid research

Connor WE, Lin DS, Thomas G, Ey F, DeLoughery T +1 more

Plain English
This study looked at the cell membranes of red blood cells in patients with sickle cell anemia compared to healthy individuals to see if their fatty acid composition was altered. Researchers found that sickle cells had 12 abnormal types of cell membrane fats, with some being 20-60% higher or lower than normal levels. These changes might contribute to complications associated with sickle cell disease, such as imbalanced minerals, dehydration, and increased blood clotting. Who this helps: This helps patients with sickle cell anemia by providing insights that could lead to better treatment options.

PubMed

Frequent Co-Authors

Thomas L Sutton Aaron Grossberg Eileen M O'Reilly Brett C Sheppard W E Connor D S Lin G Thomas T DeLoughery N Zhu

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.